Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 4 institutions in 2 countries.
Cristina BolzatiInstitute of Condensed Matter Chemistry and Energy Technologies, Consiglio Nazionale delle Ricerche, Corso Stati Uniti 4, 35127 Padova, Italy.ORCID 0000-0001-7919-516X
Carolina GobbiInstitute of Condensed Matter Chemistry and Energy Technologies, Consiglio Nazionale delle Ricerche, Corso Stati Uniti 4, 35127 Padova, Italy.
Guillermina Ferro-FloresLaboratorio Nacional de Investigación y Desarrollo de Radiofármacos, Instituto Nacional de Investigaciones Nucleares, Carretera México-Toluca S/N. La Marquesa, Ocoyoacac 52750, Mexico.ORCID 0000-0003-0296-7605
Sofia TuratoIstituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.
Blanca Ocampo-GarciaLaboratorio Nacional de Investigación y Desarrollo de Radiofármacos, Instituto Nacional de Investigaciones Nucleares, Carretera México-Toluca S/N. La Marquesa, Ocoyoacac 52750, Mexico.ORCID 0000-0002-5831-8412
Cristina MarzanoDipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via Marzolo 5, 35131 Padova, Italy.ORCID 0000-0003-0565-2596
Barbara SpolaoreDipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via Marzolo 5, 35131 Padova, Italy.ORCID 0000-0002-8284-8560
Giulio FracassoDipartimento di Scienze Biomediche, Università degli Studi di Padova, Viale G. Colombo 3, 35131 Padova, Italy.ORCID 0000-0003-3024-0307
Antonio RosatoIstituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.ORCID 0000-0002-5263-8386
Laura Meléndez-AlafortIstituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.ORCID 0000-0003-0701-3616
University of Padua · ITIstituto Oncologico Veneto · ITInstitute of Condensed Matter Chemistry and Technologies for Energy · ITInstituto Nacional de Investigaciones Nucleares · MX
Funding
5 per mille 2019 IOV- DECURTAItalian Association for Cancer Research 5 per mille 2019 ID 22759 program-G.L.Italian Association for Cancer Research AIRC-IG 2018 ID 2135Italian Association for Cancer Research AIRC-IG 2020 ID 24528
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Development and Characterization of · full record | OpenQuestion